BIG PHARMA: Chemotherapy Kills 97% of Those Who Take It

Source – hwaairfan.wordpress.com

“…people who refuse chemotherapy treatment live on average around 12 years longer than people who accept the chemotherapy treatment, most patients undergoing chemotherapy die in time frame of 3 years since they are diagnosed with cancer and some much faster than that”:

(Chemotherapy Kills 97% of Those Who Take It*)

The fact that an average cancer treatment costs somewhere between $300,000 and even up to $1,000,000 makes his statement more reasonable.

Based on his research in the last 25 years Dr. Jones has come to the conclusion that chemotherapy does more harm to the patients than actually treating the cancer. He says that people who refuse chemotherapy treatment live on average around 12 years longer than people who accept the chemotherapy treatment, most patients undergoing chemotherapy die in time frame of 3 years since they are diagnosed with cancer and some much faster than that (within few weeks since being diagnosed.) He also claims that patients with breast cancer who reject treatment live four times longer than those who undergo chemotherapy.

America spends $8,713 per capita on healthcare, more than any other high-income nation in the world and their life expectancy is only 78,8 years. This Is mainly due to the fact that the media and the healthcare system in general focus way more on treating diseases and conditions that actually teaching people about the importance of preventative medicine. That is why we need to educate ourselves about treatments and cures for different diseases and conditions.
Having a healthy diet, exercising, not stressing out and enjoying life are great for improving our health and living a longer and happier life.

https://hwaairfan.wordpress.com/

day keeps the Chemo away | Cannabis Enthusiast | Pinterest

Related…

Better Than Chemo: Turmeric Kills Cancer Not Patients – By Sayer Ji, Founder

About one hundred times less toxic than chemotherapy, turmeric extract (curcumin) was found more effective at killing colorectal cancer stem cells from patients than a popular combination of conventional drugs.

Researchers from the United Kingdom have just made a major breakthrough in cancer research by demonstrating for the first time in patient-derived colorectal cell lines that a turmeric extract (curcumin) is not only an effective adjunct agent to enhance conventional chemotherapy, but that it may be even more effective on its own.

Published this month in Cancer Letters and titled, “Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy,” the study evaluated the so-called “diet-derived agent” curcumin — the primary polyphenol in turmeric — as a possible adjunct to enhance conventional treatment of colorectal cancer with chemotherapy.

click to view the full free study

The primary role of cancer stem cells in contributing to cancer malignancy as well as resistance to conventional treatment is addressed in the study. Whereas traditional cancer research methods focus on a treatment’s ability to reduce tumor volume (or the number of cells in a cancer cell culture), the cancer stem cell theory acknowledges that treatments have highly differential effects on the different cell types that comprise the tumor; namely, whereas the relatively benign daughter cells of a tumor may die when exposed to chemotherapy, the relatively chemotherapy-resistant cancer stem cell population (so-called “mother” cells) can actually increase in number as the tumor volume decreases, resulting in creating an albeit smaller but far more dangerous, treatment-resistant tumor.

The study design and results were summarized in the abstract below:

Here, we utilised patient-derived colorectal liver metastases (CRLM) to assess whether curcumin may provide added benefit over 5-fluorouracil (5-FU) and oxaliplatin (FOLFOX) in cancer stem cell (CSC) models. Combination of curcumin with FOLFOX chemotherapy was then assessed clinically in a phase I dose escalation study. Curcumin alone and in combination significantly reduced spheroid number in CRLM CSC models, and decreased the number of cells with high aldehyde dehydrogenase activity (ALDHhigh/CD133−). Addition of curcumin to oxaliplatin/5-FU enhanced anti-proliferative and pro-apoptotic effects in a proportion of patient-derived explants, whilst reducing expression of stem cell-associated markers ALDH and CD133. The phase I dose escalation study revealed curcumin to be a safe and tolerable adjunct to FOLFOX chemotherapy in patients with CRLM (n = 12) at doses up to 2 grams daily.”

As you can see above, the researchers discovered that curcumin is both a safe and effective adjunct in the treatment of colorectal cancer. They noted the significance of these findings by pointing out that this was “the first time that curcumin may enhance oxaliplatin/5-FU-based chemotherapy in models derived directly from patients for whom the treatments are ultimately intended.” Specifically, the curcumin was able to inhibit what is known as “spheroid formation,” a 3-dimensional configuration of cells that indicates cancer stem cell driven cancer progression. Curcumin was also found to down-regulate cancer stem cell associated markers (e.g., CD44 and CD166 and ALDH activity), and various other chemical signals associated with carcinogenesis (e.g., epidermal growth factor, insulin-like growth factor and Notch). All these activities, taken together, indicate that curcumin is capable of targeting the stem cells at the heart of cancer malignancy. You can learn more about this in a previous article we wrote documenting curcumin’s ability to kill cancer stem cells: “Turmeric Extract Strikes To the Root Cause of Cancer Malignancy.” We also featured turmeric extract’s ability to selectively target cancer cells while leaving healthy ones intact in a previous article titled, “Turmeric’s ‘Smart Kill’ Properties Put Chemo & Radiation To Shame.”

Read Full Article – Continue to Page 2

http://www.greenmedinfo.com/blog/better-chemo-turmeric-kills-cancer-not-patients-1

One thought on “BIG PHARMA: Chemotherapy Kills 97% of Those Who Take It

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s